BioLife Solutions BLFS Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by BioLife Solutions in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioLife Solutions's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioLife Solutions's investing cash flow?
- BioLife Solutions (BLFS) reported investing cash flow of -$1.83M in Q1 2026.
- How has BioLife Solutions's investing cash flow changed year-over-year?
- BioLife Solutions's investing cash flow increased by 93.3% year-over-year, from -$27.18M to -$1.83M.
- What is the long-term trend for BioLife Solutions's investing cash flow?
- Over 4 years (2021 to 2025), BioLife Solutions's investing cash flow has grown at a 53.2% compound annual growth rate (CAGR), from -$13.19M to -$72.68M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.